查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1671138

乳房病變局部存在化法的全球市場:市場規模·佔有率·趨勢，產業分析 (各類型·各地區)，未來預測 (2025年～2034年)

Breast Lesion Localization Methods Market Size, Share, Trends, Industry Analysis Report: By Type and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 119 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 最近的一項研究，全球乳房病變定位市場預計到 2034 年將達到 47.2306 億美元。該研究報告對當前的市場動態提供了詳細的見解，並對未來的市場成長進行了分析。

乳房病變定位市場受到多種因素的推動，例如乳癌盛行率的增加、影像技術的進步以及對微創手術的需求不斷增加。人們對早期發現的認識不斷提高以及手術結果的改善也促進了乳房病變定位市場的成長。一個關鍵趨勢是轉向更精確、更患者友善的技術，例如使用放射性種子或磁性示蹤劑進行定位，以最大限度地減少不適並縮短恢復時間。

乳房病變定位的市場機會存在於新興地區，特別是亞太地區和拉丁美洲，這些地區的醫療保健基礎設施正在改善，對乳癌檢測技術的需求也在不斷增長。隨著個人化治療方法和創新技術的不斷發展，並專注於提高精準度和患者護理，預計市場將實現穩步成長。

乳房病變定位市場：分析概述

根據類型，有線引導定位繼續成為市場的主導部分，因為它因其已建立的可靠性和簡單性而被廣泛使用。在轉變為微創治療的背景下，放射性同位素定位由於其準確性和患者舒適度而正在經歷最快的增長。

北美由於採用了先進的在地化技術和完善的醫療保健體係而佔據全球市場主導地位。同時，隨著醫療保健基礎設施的改善、乳癌意識的不斷提高以及先進診斷技術的不斷採用，亞太地區的乳房病變定位市場正在快速成長。

該市場的主要參與者包括 Hologic、CR Bard（被 BD 收購）、MiMedx Group 和 Cook Medical，提供各種定位技術，包括導絲技術和放射性同位素技術。其他主要貢獻者包括磁性種子定位專家 Endomag 和乳癌手術定位產品供應商 IZI Medical Products。

目錄

第1章 簡介

第2章 摘要整理

第3章 分析方法

第4章 乳房病變局部存在化法市場洞察

  • 市場概述
  • 乳房病變局部存在化法的市場動態
    • 促進因素和機會
      • 影像技術的進步
      • 轉向微創手術
      • 擴大採用個人化和有針對性的治療方法
    • 阻礙因素與課題
      • 治療成本高
  • 大環境分析
  • 乳房病變局部存在化法市場趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球乳房病變局部存在化法市場:各類型

  • 主要的分析結果
  • 簡介
  • 線誘導式位置特定
  • 放射性同位元素式位置特定
  • 磁描繪器
  • 其他

第6章 全球乳房病變局部存在化法市場:各地區

  • 主要的分析結果
  • 簡介
    • 乳房病變局部存在化法市場評估:各地區 (2020～2034年)
  • 北美
    • 北美:各類型 (2020～2034年)
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各類型 (2020～2034年)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各類型 (2020～2034年)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各類型 (2020～2034年)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:各類型 (2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第7章 競爭情形

  • 事業擴大·企業收購的分析
    • 事業擴大
    • 企業收購
  • 聯盟/合作/協定/公開

第8章 企業簡介

  • Hologic Inc.
  • C.R. Bard(acquired by BD)
  • MiMedx Group Inc.
  • Cook Medical
  • Endomag
  • IZI Medical Products
  • Thermo Fisher Scientific
  • GE Healthcare
  • Magee-Womens Hospital
  • Siemens Healthineers
  • Medtronic
  • Philips Healthcare
  • Fujifilm Corporation
  • Johnson & Johnson
  • Canon Medical Systems
Product Code: PM1337

The global breast lesion localization methods market size is expected to reach USD 4,723.06 million by 2034, according to a new study by Polaris Market Research. The report "Breast Lesion Localization Methods Market Size, Share, Trends, Industry Analysis Report: By Type (Wire Guided Localization, Radioisotope Localization, Magnetic Tracer, and Others) and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The breast lesion localization methods market is driven by several factors, including the increasing prevalence of breast cancer, advancements in imaging technologies, and growing demand for minimally invasive procedures. The rising awareness of early detection and improved surgical outcomes also contribute to the breast lesion localization methods market growth. Key trends include the shift towards more precise, patient-friendly techniques such as radioactive seed and magnetic tracer localization, which minimize discomfort and reduce recovery times.

Breast lesion localization methods market opportunities exist in emerging regions, particularly in Asia Pacific and Latin America, where healthcare infrastructure is improving, and the demand for breast cancer detection technologies is rising. As personalized treatment approaches and innovative technologies continue to evolve, the market is expected to experience steady growth, with a focus on enhancing both accuracy and patient care.

Breast Lesion Localization Methods Market Report Highlights

Based on type, wire guided localization remains the dominant segment in the market, as it is widely used due to its established reliability and simplicity. The radioisotope localization segment is experiencing the fastest growth, driven by its precision and patient comfort, with an increasing shift towards minimally invasive procedures.

North America dominates the global market, with strong adoption of advanced localization technologies and well-established healthcare systems. Meanwhile, the Asia Pacific breast lesion localization methods market is witnessing rapid growth, supported by improving healthcare infrastructure, rising breast cancer awareness, and increasing adoption of advanced diagnostic methods.

A few of the key players in the market include Hologic Inc., C.R. Bard (acquired by BD), MiMedx Group Inc., and Cook Medical, which offer a range of localization technologies, such as wire-guided and radioisotope methods. Other significant contributors are Endomag, which specializes in magnetic seed localization, and IZI Medical Products, a supplier of localization products for breast cancer surgery.

Polaris Market Research has segmented the breast lesion localization methods market report on the basis of type and region:

By Type Outlook (Revenue-USD Million, 2020-2034)

  • Wire Guided Localization
  • Radioisotope Localization
  • Magnetic Tracer
  • Others

By Regional Outlook (Revenue-USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Breast Lesion Localization Methods Market Insights

  • 4.1. Breast Lesion Localization Methods Market - Market Snapshot
  • 4.2. Breast Lesion Localization Methods Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in Imaging Technologies
      • 4.2.1.2. Shift Toward Minimally Invasive Procedures
      • 4.2.1.3. Rising Adoption of Personalized and Targeted Treatment Approaches
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of the Methods
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Breast Lesion Localization Methods Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Breast Lesion Localization Methods Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • 5.3. Wire Guided Localization
    • 5.3.1. Global Breast Lesion Localization Methods Market, by Wire Guided Localization, by Region, 2020-2034 (USD Million)
  • 5.4. Radioisotope Localization
    • 5.4.1. Global Breast Lesion Localization Methods Market, by Radioisotope Localization, by Region, 2020-2034 (USD Million)
  • 5.5. Magnetic Tracer
    • 5.5.1. Global Breast Lesion Localization Methods Market, by Magnetic Tracer, by Region, 2020-2034 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Breast Lesion Localization Methods Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Breast Lesion Localization Methods Market, by Geography

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Breast Lesion Localization Methods Market Assessment, by Geography, 2020-2034 (USD Million)
  • 6.3. Breast Lesion Localization Methods Market - North America
    • 6.3.1. North America: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.3.2. Breast Lesion Localization Methods Market - US
      • 6.3.2.1. US: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.3.3. Breast Lesion Localization Methods Market - Canada
      • 6.3.3.1. Canada: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • 6.4. Breast Lesion Localization Methods Market - Europe
    • 6.4.1. Europe: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.2. Breast Lesion Localization Methods Market - UK
      • 6.4.2.1. UK: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.3. Breast Lesion Localization Methods Market - France
      • 6.4.3.1. France: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.4. Breast Lesion Localization Methods Market - Germany
      • 6.4.4.1. Germany: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.5. Breast Lesion Localization Methods Market - Italy
      • 6.4.5.1. Italy: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.6. Breast Lesion Localization Methods Market - Spain
      • 6.4.6.1. Spain: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.7. Breast Lesion Localization Methods Market - Netherlands
      • 6.4.7.1. Netherlands: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.8. Breast Lesion Localization Methods Market - Russia
      • 6.4.8.1. Russia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.9. Breast Lesion Localization Methods Market - Rest of Europe
      • 6.4.9.1. Rest of Europe: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • 6.5. Breast Lesion Localization Methods Market - Asia Pacific
    • 6.5.1. Asia Pacific: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.2. Breast Lesion Localization Methods Market - China
      • 6.5.2.1. China: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.3. Breast Lesion Localization Methods Market - India
      • 6.5.3.1. India: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.4. Breast Lesion Localization Methods Market - Malaysia
      • 6.5.4.1. Malaysia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.5. Breast Lesion Localization Methods Market - Japan
      • 6.5.5.1. Japan: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.6. Breast Lesion Localization Methods Market - Indonesia
      • 6.5.6.1. Indonesia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.7. Breast Lesion Localization Methods Market - South Korea
      • 6.5.7.1. South Korea: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.8. Breast Lesion Localization Methods Market - Australia
      • 6.5.8.1. Australia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.9. Breast Lesion Localization Methods Market - Rest of Asia Pacific
      • 6.5.9.1. Rest of Asia Pacific: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • 6.6. Breast Lesion Localization Methods Market - Middle East & Africa
    • 6.6.1. Middle East & Africa: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.6.2. Breast Lesion Localization Methods Market - Saudi Arabia
      • 6.6.2.1. Saudi Arabia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.6.3. Breast Lesion Localization Methods Market - UAE
      • 6.6.3.1. UAE: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.6.4. Breast Lesion Localization Methods Market - Israel
      • 6.6.4.1. Israel: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.6.5. Breast Lesion Localization Methods Market - South Africa
      • 6.6.5.1. South Africa: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.6.6. Breast Lesion Localization Methods Market - Rest of Middle East & Africa
      • 6.6.6.1. Rest of Middle East & Africa: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • 6.7. Breast Lesion Localization Methods Market - Latin America
    • 6.7.1. Latin America: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.7.2. Breast Lesion Localization Methods Market - Mexico
      • 6.7.2.1. Mexico: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.7.3. Breast Lesion Localization Methods Market - Brazil
      • 6.7.3.1. Brazil: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.7.4. Breast Lesion Localization Methods Market - Argentina
      • 6.7.4.1. Argentina: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.7.5. Breast Lesion Localization Methods Market - Rest of Latin America
      • 6.7.5.1. Rest of Latin America: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)

7. Competitive Landscape

  • 7.1. Expansion and Acquisition Analysis
    • 7.1.1. Expansion
    • 7.1.2. Acquisitions
  • 7.2. Partnerships/Collaborations/Agreements/Exhibitions

8. Company Profiles

  • 8.1. Hologic Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Financial Performance
    • 8.1.3. Product Benchmarking
    • 8.1.4. Recent Development
  • 8.2. C.R. Bard (acquired by BD)
    • 8.2.1. Company Overview
    • 8.2.2. Financial Performance
    • 8.2.3. Product Benchmarking
    • 8.2.4. Recent Development
  • 8.3. MiMedx Group Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Financial Performance
    • 8.3.3. Product Benchmarking
    • 8.3.4. Recent Development
  • 8.4. Cook Medical
    • 8.4.1. Company Overview
    • 8.4.2. Financial Performance
    • 8.4.3. Product Benchmarking
    • 8.4.4. Recent Development
  • 8.5. Endomag
    • 8.5.1. Company Overview
    • 8.5.2. Financial Performance
    • 8.5.3. Product Benchmarking
    • 8.5.4. Recent Development
  • 8.6. IZI Medical Products
    • 8.6.1. Company Overview
    • 8.6.2. Financial Performance
    • 8.6.3. Product Benchmarking
    • 8.6.4. Recent Development
  • 8.7. Thermo Fisher Scientific
    • 8.7.1. Company Overview
    • 8.7.2. Financial Performance
    • 8.7.3. Product Benchmarking
    • 8.7.4. Recent Development
  • 8.8. GE Healthcare
    • 8.8.1. Company Overview
    • 8.8.2. Financial Performance
    • 8.8.3. Product Benchmarking
    • 8.8.4. Recent Development
  • 8.9. Magee-Womens Hospital
    • 8.9.1. Company Overview
    • 8.9.2. Financial Performance
    • 8.9.3. Product Benchmarking
    • 8.9.4. Recent Development
  • 8.10. Siemens Healthineers
    • 8.10.1. Company Overview
    • 8.10.2. Financial Performance
    • 8.10.3. Product Benchmarking
    • 8.10.4. Recent Development
  • 8.11. Medtronic
    • 8.11.1. Company Overview
    • 8.11.2. Financial Performance
    • 8.11.3. Product Benchmarking
    • 8.11.4. Recent Development
  • 8.12. Philips Healthcare
    • 8.12.1. Company Overview
    • 8.12.2. Financial Performance
    • 8.12.3. Product Benchmarking
    • 8.12.4. Recent Development
  • 8.13. Fujifilm Corporation
    • 8.13.1. Company Overview
    • 8.13.2. Financial Performance
    • 8.13.3. Product Benchmarking
    • 8.13.4. Recent Development
  • 8.14. Johnson & Johnson
    • 8.14.1. Company Overview
    • 8.14.2. Financial Performance
    • 8.14.3. Product Benchmarking
    • 8.14.4. Recent Development
  • 8.15. Canon Medical Systems
    • 8.15.1. Company Overview
    • 8.15.2. Financial Performance
    • 8.15.3. Product Benchmarking
    • 8.15.4. Recent Development

List of Tables:

  • Table 1 Global Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 2 North America: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 3 US: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 4 Canada: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 5 Europe: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 6 UK: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 7 France: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 8 Germany: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 9 Italy: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 10 Spain: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 11 Netherlands: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 12 Russia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 13 Rest of Europe: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 14 Asia Pacific: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 15 China: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 16 India: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 17 Malaysia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 18 Japan: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 19 Indonesia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 20 South Korea: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 21 Australia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 22 Rest of Asia Pacific: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 23 Middle East & Africa: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 24 Saudi Arabia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 25 UAE: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 26 Israel: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 27 South Africa: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 28 Rest of Middle East & Africa: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 29 Latin America: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 30 Mexico: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 31 Brazil: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 32 Argentina: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 33 Rest of Latin America: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Breast Lesion Localization Methods Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Breast Lesion Localization Methods Market, by Type, 2024 & 2034 (USD Million)